Advertisement

Topics

Latest "Southern Clinical Regulatory" News Stories - Page: 3

16:52 EST 10th December 2018 | BioPortfolio

Here are the most relevant search results for "Southern Clinical Regulatory" found in our extensive news archives from over 250 global news sources.

More Information about Southern Clinical Regulatory on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Southern Clinical Regulatory for you to read. Along with our medical data and news we also list Southern Clinical Regulatory Clinical Trials, which are updated daily. BioPortfolio also has a large database of Southern Clinical Regulatory Companies for you to search.

Showing "Southern Clinical Regulatory" News Articles 51–75 of 19,000+

Relevant

Heat is driving off clouds that dampen California wildfires


More wet and dry weather extremes projected with global warming

(Rutgers University) Global warming is projected to spawn more extreme wet and dry weather around the world, according to a Rutgers-led study. Those extremes include more frequent dry spells in the northwestern, central and southern United States and in Mexico, and more frequent heavy rainfall events in south Asia, the Indochinese Peninsula and southern China.

Air pollution affects thyroid development in fetuses, USC research finds

(University of Southern California) Soot and dust alters thyroid development in fetuses before they are born in smoggy cities, raising concern about health impacts later in life, new USC research shows. Scientists focused on more than 2,000 kids in smoggy Southern California as part of USC's ongoing Children's Health Study.


CRSP Falls On Clinical Hold, PFE Gets FDA Nod, ARWR To Report Data In Nov.

Today's Daily Dose brings you news about clinical hold on CRISPR's CTX001 for sickle cell disease; new findings from ContraVir's pre-clinical study of CRV431 in a hepatocellular carcinoma mouse model; positive data from Gilead's psoriatic arthritis study; FDA approval for expanded use of Pfizer's Xeljanz and Sage Therapeutics' upcoming regulatory catalyst.

New hope for white rhino, world’s most endangered mammal

AGTC Announces Expansion of Clinical and Regulatory Leadership Teams

20+ Year Medical Affairs and Ophthalmology Veteran, Lanita C. Scott, M.D., Appointed as Vice President of Clinical Research and Medical Affairs Karen M. Carroll, RN, Named Vice President of Clinical Development Operations GAINESVILLE, Fla. and CAMBRIDGE, Mass., June 14, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human c...

Southern diet may be largest factor leading to higher rates of hypertension in US black populations

1. In this prospective cohort study, the higher rate of hypertension in black patients than white patients was most strongly influenced by a Southern diet in both men and women. 2. Other dietary and socioeconomic factors were also associated with the increased incidence of hypertension in black patients. Evidence Rating Level: 2 (Good) Study Rundown: […]

Why The EU’s New Clinical Trials System Is Taking So Long

Technical complexities mean that the finalization of the EU’s much vaunted clinical trial portal and database system has be...

Merck Paves the Way for its Innovation Hub in Southern China

Merck signed an agreement with the Guangzhou Development District on innovation development in Southern China. Pursuant to this agreement, Merck will establish an innovation hub in Guangzhou scheduled to open September 2019. “China is a major innovation hotspot and one of our most important growth m...

Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease

CRANBURY, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases, announced today regulatory and clinical advancements in its development program AT-GAA for Pompe disease.   During the third quarter, Amicus held a Type C meeting with the United S...

Week Ahead In Pharmaceuticals: 11 Stocks To Watch (MRTX, EPZM, ITCI...)

Biotech stocks are very volatile as they are driven by clinical trial data and regulatory decisions. Let's take a look at the companies that are scheduled to report/update their clinical trial results this week.

Carbon 'leak' may have warmed the planet for 11,000 years, encouraging human civilization

(Princeton University) The oceans lock away atmospheric carbon dioxide, but a 'leak' in the Southern Ocean brings the greenhouse gas back into the atmosphere. An international research team looked at minute nitrogen concentrations embedded in diatoms, forams and corals to identify an increase in Southern Ocean upwelling during the past 11,000 years, which could explain the otherwise mysterious wa...

Growth of Greenlandic children is no longer stunted

(University of Southern Denmark Faculty of Health Sciences) Previous studies of growth of the indigenous Inuit people of Greenland, Canada and Alaska has characterized them as shorter but with the same weight as European or continental US citizens. Yet, this specific growth pattern was no longer found in the new study of growth of Greenlandic children conducted by researchers from University of So...

Avillion: Lewis Cameron, an innovative model for clinical development.

Lewis Cameron CEO, talks about the companies objective, with a strong focus on helping partners develop their drug candidate by incurring 100% of the clinical and regulatory risks, while Pharma will maintain absolute ownership of and control on commercialising the asset.

Southern Research selects Stacey Kelpke as head of AIMTech initiative

In her new role, Kelpke oversees a program that aims to accelerate the development of early-stage medical device technologies as potential commercial products through prototyping, market validation, and The post Southern Research selects Stacey Kelpke as head of AIMTech initiative appeared first on Compelo Medical Devices.

Amicus Therapeutics Announces European Regulatory and Clinical Updates for AT-GAA in Pompe Disease

CRANBURY, N.J., June 26, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases, announced today regulatory and clinical advancements in its development program for AT-GAA for Pompe disease following guidance from regulators in the European Union as well as guidance ...

China reports new African swine fever outbreak in southern Hunan province

China's agriculture ministry said on Monday it had confirmed a new outbreak of African swine fever in southern Hunan province.

MHRA consults on new regulatory framework for ‘no-deal’ scenario

The Medicines and Healthcare products Regulatory Agency has launched a consultation seeking views on how its legislation and regulatory processes would have to be modified if the UK leaves the EU under a ‘no-deal’ scenario.

In Southern Mozambique, only half of people diagnosed with HIV enroll in medical care

(Barcelona Institute for Global Health (ISGlobal)) HIV diagnosis is the first of many steps in the path to global disease control. However, in Southern Mozambique, more than half of people diagnosed with HIV do not initiate the next steps in the cascade of HIV care, and this is particularly true for those that perform the test at home. The study, led by ISGlobal, reveals the need to develop interv...

Oncobiologics Changes Name to Outlook Therapeutics; Announces Next Steps in Executing ONS-5010 Clinical and Regulatory Strategy

Company changes name to Outlook Therapeutics, Inc.; ticker symbol to “OTLK”Jeff Evanson joins team as Chief Commercial OfficerTerry Dagnon joins team as Chief Operating OfficerClosed second tranche of private placement for additional $4.0 million from BioLexis CRANBURY, N.J., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (the “Company”) today announced several key ...

Moleculin Seeks Approval from Polish Regulatory Agency for Skin Cancer Clinical Trial

HOUSTON, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today announced it has submitted a request to Polish author...

Mortality in Asthma-COPD Overlap in the United States

Asthma-COPD overlap, or ACO, is recognized as a distinct clinical entity. What are the predominant causes of mortality among patients with ACO, and do they differ from those with asthma or COPD alone? Southern Medical Journal

UFCW Locals 135, 324, 770, 1167, 1428, 1442, and 8GS & Rite Aid Reach Three Year Contract Agreement Covering Company’s Southern California Stores

After renewed negotiations that have taken place over the last few days, the UFCW and Rite Aid are pleased to announce that they have reached a three-year agreement, covering over 5,900 Rite Aid associates at 357 stores across Southern California. As a result of this agreement, which requires ratification by associates, the UFCW has lifted its cal...

An increase in Southern Ocean upwelling may explain the Holocene CO2 rise

(Max Planck Institute for Chemistry) During the 10 000 years preceding the industrial revolution, there was a small but significant increase in atmospheric CO2 concentrations which may have played a crucial role in stabilizing the climate of the Holocene epoch. An international team led by scientists from the Max Planck Institute for Chemistry and Princeton University now suggest that an increase ...

Natural History Museum partners with USC for augmented reality experiences at La Brea Tar Pits

(University of Southern California) In a new partnership between the Natural History Museums of Los Angeles County (which includes the La Brea Tar Pits and Museum) and University of Southern California, researchers will seek to understand how best to design augmented reality experiences for effective learning.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks